Search - tctmd.com

Displaying 1 - 20 of 217

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

L.A. McKeown

December 11, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients

Michael O'Riordan

December 05, 2023

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Daily News

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

L.A. McKeown

December 01, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Conference News AHA 2023

For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent

Caitlin E. Cox

November 17, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

L.A. McKeown

November 17, 2023

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Who Benefits Most From Semaglutide and How Long Will That Take?

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Statin Use Has Plateaued in US Primary Prevention Patients

JACC Statement Focuses on PAD Disparities, Gaps in Care

Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose

December 2023 Dispatch for the CV Team

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

For LGBTQ+ Patients With Heart Failure, EMR Details Often Absent

Mortality Risk Varies Among Patients With Very High LDL Levels

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Dapagliflozin in myocardial infarction without diabetes or heart failure

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content